Kim E Nichols, MD
Affiliations: | 2012 | Children's Hospital of Philadelphia | University of Pennsylvania Perelman School of Medicine |
| 2012- | St Jude Children's Research Hospital, New York, NY, United States |
Area:
Oncology, Cancer Predisposition, NKT cell biologyGoogle:
"Kim Nichols"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bloom M, Oak N, Baskin-Doerfler R, et al. (2023) ETV6 Represses Inflammatory Response Genes and Regulates HSPC Function During Stress Hematopoiesis in Mice. Blood Advances |
| Shakoory B, Geerlinks A, Wilejto M, et al. (2023) The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Annals of the Rheumatic Diseases |
| Shakoory B, Geerlinks A, Wilejto M, et al. (2023) The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS). Arthritis & Rheumatology (Hoboken, N.J.) |
| Steen EA, Nichols KE, Meyer LK. (2023) Insights into the cellular pathophysiology of familial hemophagocytic lymphohistiocytosis. Frontiers in Immunology. 14: 1147603 |
| Hines MR, Keenan C, Maron Alfaro G, et al. (2021) Hemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific CAR T-cell therapy. British Journal of Haematology |
| Li Y, Yang W, Devidas M, et al. (2021) Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia. The Journal of Clinical Investigation |
| Hines MR, Nichols KE. (2021) HLH or sepsis: the truth is in the T cells. Blood. 137: 2279-2280 |
| Guan P, Schaub R, Nichols KE, et al. (2020) Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control. International Journal of Molecular Sciences. 21 |
| Patel NP, Guan P, Bahal D, et al. (2020) Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody. International Journal of Molecular Sciences. 21 |
| Meyer L, Verbist KC, Albeituni S, et al. (2020) JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation. Blood |